Publication | Open Access

Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes

InflammationMetabolic SyndromeType 1MedicineDiabetesPhysiologyChronic Kidney DiseaseDiabetic Kidney DiseaseRat ModelRenal InjuryDiabetes MellitusPharmacologyNephrologyHealth Sciences